
Sign up to save your podcasts
Or
From Eli Lilly’s provocative Oscars ad to AI-powered therapy backlash, this episode of The No Normal Show goes deep into the forces reshaping trust in healthcare. The latest data from The Wall Street Journal shows confidence in doctors is plummeting, AI is disrupting care delivery, and alternative health movements are gaining ground. What does this mean for healthcare leaders? How should marketing teams rethink their approach to patient engagement and brand credibility? We break down the key trends, the marketing implications, and what healthcare brands must do to stay ahead. Let's chat.
4.6
1111 ratings
From Eli Lilly’s provocative Oscars ad to AI-powered therapy backlash, this episode of The No Normal Show goes deep into the forces reshaping trust in healthcare. The latest data from The Wall Street Journal shows confidence in doctors is plummeting, AI is disrupting care delivery, and alternative health movements are gaining ground. What does this mean for healthcare leaders? How should marketing teams rethink their approach to patient engagement and brand credibility? We break down the key trends, the marketing implications, and what healthcare brands must do to stay ahead. Let's chat.